Physician profile
Kyle Mitchell Bess
NPI 1194187260
$21,264.96
in general payments reported to CMS, 2019-2025
21 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.37 · 2020: $192 · 2021: $269 · 2022: $589 · 2023: $1,849 · 2024: $445 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $9,000 · Travel and Lodging: $7,000 · Education: $2,250 · Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $9,000.00 |
| Travel and Lodging | $6,999.72 |
| Education | $2,250.00 |
| Food and Beverage | $1,881.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cmr Surgical, INC. | $12,323.18 | 2025 | Versius Surgical System (Versius Plus) |
| Intuitive Surgical, INC. | $5,249.79 | 2021-2025 | Da Vinci Surgical System |
| Davol INC. | $2,315.63 | 2021-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $531.52 | 2022-2024 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Baxter Healthcare | $166.01 | 2019-2022 | |
| Conmed Corporation | $142.16 | 2022 | |
| Covidien Lp | $117.35 | 2020 | |
| Medtronic Vascular, INC. | $75.13 | 2020 | |
| Angiodynamics, INC. | $56.38 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Tela Bio, INC. | $45.54 | 2022 | |
| Hologic INC | $45.53 | 2022 | |
| Ethicon US, LLC | $30.22 | 2021 | |
| Veryan Medical Incorporated | $29.74 | 2023 | Biomimics 3d Vascular Stent System |
| Shockwave Medical, INC | $27.98 | 2021 | |
| Silk Road Medical, INC. | $19.78 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $17.04 | 2024 | Promogran Prisma, V.A.C. Veraflo, Activ.A.C. |
| Myriad Genetic Laboratories, INC. | $16.74 | 2022 | |
| Sanara Medtech INC. | $16.51 | 2024 | Celleraterx |
| Kowa Pharmaceuticals America, INC. | $14.71 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $12.28 | 2022 | |
| Bioventus LLC | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Bess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.